Ronna H. Berezin

Cost-Effectiveness of Sirolimus-Eluting Stents for Treatment of Complex Coronary Stenoses

Ameet Bakhai, Chunxue Shi, Louise Githiora et al. · Circulation · 2004 · 236 citations · Full text

Medicine, Cardiology, Pharmacoeconomics +12

Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention

A. Michael Lincoff, Tara A. Lavelle, Huei-Ling Chen et al. · Journal of the American College of Cardiology · 2004 · 119 citations

Medicine, Cardiology, Pharmacotherapy +16

Economic Evaluation of Bivalirudin With or Without Glycoprotein IIb/IIIa Inhibition Versus Heparin With Routine Glycoprotein IIb/IIIa Inhibition for Early Invasive Management of Acute Coronary Syndromes

Duane S. Pinto, Gregg W. Stone, Chunxue Shi et al. · Journal of the American College of Cardiology · 2008 · 78 citations

Medicine, Cardiology, Pharmacotherapy +17

Cost Effectiveness of Paclitaxel-Eluting Stents for Patients Undergoing Percutaneous Coronary Revascularization

Ameet Bakhai, Gregg W. Stone, Elizabeth M. Mahoney et al. · Journal of the American College of Cardiology · 2006 · 74 citations

Medicine, Cardiology, Pharmacoeconomics +16

Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts

Sabina A. Murphy, Donald S. Baim, Tara A. Lavelle et al. · Journal of the American College of Cardiology · 2004 · 33 citations

Medicine, Pharmacoeconomics, Surgery +13